Advertisement

Journal of Anesthesia

, Volume 26, Issue 5, pp 689–695 | Cite as

Effects of dose ranging of adenosine infusion on electrocardiographic findings during and after general anesthesia

  • Yan-Xia Sun
  • Ashraf S. Habib
  • Tom Wenger
  • Irwin Gratz
  • David Glick
  • Rishimani Adsumelli
  • Mary R. Creed
  • Tong J. GanEmail author
Original Article

Abstract

Purpose

To assess changes in the electrocardiogram (ECG) associated with intraoperative infusion of adenosine in patients undergoing open abdominal gynecological surgery.

Methods

One hundred and sixty-six patients undergoing gynecological surgery were randomly assigned to receive one of four doses of adenosine infusion (25, 50, 100, or 200 μg/kg/min) or matching placebo. Study drug administration was started at skin incision and discontinued at end of surgery. A standardized general anesthetic regimen was used and adjusted based on hemodynamic and bispectral index values. Heart rate and rhythm variables, and PR, QRS, QT, and QTc intervals were recorded from 12-lead ECGs before anesthesia and immediately after patient arrival in the postanesthesia care unit. In addition, a rhythm strip was obtained during administration of the loading dose of the study drug. ECG variables were compared within and between groups. Incidence of ECG and hemodynamic abnormalities was recorded.

Results

One hundred and fifty-one subjects had a full set of electrocardiographic data: placebo (n = 38), group adenosine 25 μg/kg/min (n = 31), group adenosine 50 μg/kg/min (n = 29), group adenosine 100 μg/kg/min (n = 28), and group adenosine 200 μg/kg/min (n = 25). Statistically significant postoperative QTc prolongation was observed in all study groups when compared with baseline except for the adenosine 200 μg/kg/min group. However, these changes from baseline were not different among the groups. There were also no significant differences in PR, QRS, and QT intervals between the treatment groups.

Conclusion

There was no difference in QTc prolongation following intraoperative administration of adenosine infusion compared with placebo during isoflurane general anesthesia. However, QTc prolongation is common following general anesthesia.

Keywords

Adenosine QTc ECG General anesthesia 

Notes

Acknowledgments

The authors thank the following clinical investigators in the Adenosine Perioperative Trial Group for participating in this trial: David Adams, MD, University of Vermont, Burlington, VT; Kumar Belani, MD, University of Minnesota, Minneapolis, MN; Keith Candiotti, MD, University of Miami Jackson Memorial Hospital, Miami, FL; Ashraf Habib, MD, Duke University Medical Center, Durham, NC; Irwin Gratz, MD, Cooper Hospital University Medical Center, Camden, NJ; Michael O’Connor, MD, University of Chicago, Chicago, IL; Rishimani Adsumelli, MD, Stony Brook University Hospital, Stony Brook, NY; Eugene Viscusi, MD, Thomas Jefferson University, Philadelphia, PA; Babatunde Ogunnaike, MD, UT Southwestern Medical Center at Dallas, Dallas, TX; Ashish Sinha, MD, University of Pennsylvania, Philadelphia, PA; James B. Mayfield, MD, Medical College of Georgia, Augusta, GA; Harold Minkowitz, MD, Memorial Hermann Healthcare System, Memorial City Hospital, Houston, TX; Timothy C. Osborn, MD, Tomball Memorial Hospital, Tomball, TX; Spencer Yost, MD, University of California, San Francisco, San Francisco, CA; R. Kevin Jones, MD, Accurate Clinical Trials Inc., San Clemente, CA; Howard Miller, MD, The Woman’s Hospital of Texas, Houston, TX. This study was supported by Xsira, Inc.

References

  1. 1.
    Williams M. Adenosine antagonists. Med Res Rev. 1989;9:19–43.CrossRefGoogle Scholar
  2. 2.
    Montesinos MC, Gadangi P, Longaker M, Sung J, Levine J, Nilsen D, Reibman J, Li M, Jiang CK, Hirschhorn R, Recht PA, Ostad E, Levin RI, Cronstein BN. Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med. 1997;186:1615–20.PubMedCrossRefGoogle Scholar
  3. 3.
    Cronstein BN, Naime D, Firestein G. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum. 1995;38:1040–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Faulds D, Chrisp P, Buckley MM. Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia. Drugs. 1991;41:596–624.PubMedCrossRefGoogle Scholar
  5. 5.
    Sawynok J, Reid A, Poon A. Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test. Pain. 1998;74:75–81.PubMedCrossRefGoogle Scholar
  6. 6.
    Lynch ME, Clark AJ, Sawynok J. Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrollment design. Pain. 2003;103:111–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Segerdahl M, Ekblom A, Sandelin K, Wickman M, Sollevi A. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics. Anesth Analg. 1995;80:1145–9.PubMedGoogle Scholar
  8. 8.
    Segerdahl M, Irestedt L, Sollevi A. Antinociceptive effect of perioperative adenosine infusion in abdominal hysterectomy. Acta Anaesthesiol Scand. 1997;41:473–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Segerdahl M, Persson E, Ekblom A, Sollevi A. Peroperative adenosine infusion reduces isoflurane concentrations during general anesthesia for shoulder surgery. Acta Anaesthesiol Scand. 1996;40:792–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Fukunaga AF, Alexander GE, Stark CW. Characterization of the analgesic actions of adenosine: comparison of adenosine and remifentanil infusions in patients undergoing major surgical procedures. Pain. 2003;101:129–38.PubMedCrossRefGoogle Scholar
  11. 11.
    Viskin S. Long QT syndromes and torsade de pointes. Lancet. 1999;354:1625–33.PubMedCrossRefGoogle Scholar
  12. 12.
    Booker PD, Whyte SD, Ladusans EJ. Long QT syndrome and anaesthesia. Br J Anaesth. 2003;90:349–66.PubMedCrossRefGoogle Scholar
  13. 13.
    Roden DM. Drug-induced prolongation of QT interval. N Engl J Med. 2004;350:1013–22.PubMedCrossRefGoogle Scholar
  14. 14.
    Guideri F, Ferber D, Galgano G, Isidori S, Blardi P, Pasini FL, Di Perri T. QTc interval prolongation during infusion with dipyridamole or adenosine. Int J Cardiol. 1995;48:67–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S. Adenosine induced torsades de pointes in a child with congenital long QT syndrome. Pacing Clin Electrophysiol. 1994;17:1814–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Bazett HC. The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. J Physiol. 1920;53:320–39.PubMedGoogle Scholar
  17. 17.
    Drew BJ, Califf RM, Funk M, Kaufman ES, Krucoff MW, Laks MM, Macfarlane PW, Sommargren C, Swiryn S, Van Hare CF. Practice standards for electrocardiographic monitoring in hospital setting: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses. Circulation. 2004;110:2721–46.PubMedCrossRefGoogle Scholar
  18. 18.
    Habib AS, Minkowitz H, Osborn T, Ogunnaike B, Candiotti K, Viscusi E, Gu J, Creed M, Gan TJ, Adenosine Study Group. Phase 2, double-blind, placebo-controlled, dose-response trial of intravenous adenosine for perioperative analgesia. Anesthesiology. 2008;109:1085–91.PubMedCrossRefGoogle Scholar
  19. 19.
    Crouch MA, Limon L, Cassano AT. Clinical relevance and management of drug-related QT interval prolongation. Pharmacotherapy. 2003;23:881–908.PubMedCrossRefGoogle Scholar
  20. 20.
    Charbit B, Albaladejo P, Funck-Brentano C, Legrand M, Samain E, Marty J. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology. 2005;102:1094–100.PubMedCrossRefGoogle Scholar
  21. 21.
    Kleinsasser A, Kuenszberg E, Loeckinger A, Keller C, Hoermann C, Lindner KH, Puehringer F. Sevoflurane, but not propofol, significantly prolongs the Q–T interval. Anesth Analg. 2000;90:25–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Kuenszberg E, Loeckinger A, Kleinsasser A, Lindner KH, Puehringer F, Hoermann C. Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur J Anaesthesiol. 2000;17:662–4.PubMedGoogle Scholar
  23. 23.
    Michaloudis D, Fraidakis O, Petrou A, Gigourtsi C, Parthenakis F. Anaesthesia and the QT interval. Effects of isoflurane and halothane in unpremedicated children. Anaesthesia. 1998;53:435–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Michaloudis D, Fraidakis O, Lefaki T, Kanakoudis F, Askitopoulou H. Anaesthesia and the QT interval in humans: effects of halothane and isoflurane in premedicated children. Eur J Anaesthesiol. 1998;15:623–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol. 1991;18:718–29.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 2012

Authors and Affiliations

  • Yan-Xia Sun
    • 1
  • Ashraf S. Habib
    • 2
  • Tom Wenger
    • 3
  • Irwin Gratz
    • 4
  • David Glick
    • 5
  • Rishimani Adsumelli
    • 6
  • Mary R. Creed
    • 7
  • Tong J. Gan
    • 2
    Email author
  1. 1.Department of Anesthesiology, TongRen HospitalCapital Medical UniversityBeijingChina
  2. 2.Department of AnesthesiologyDuke University Medical CenterDurhamUSA
  3. 3.Wenger ConsultingDurhamUSA
  4. 4.UMDNJ Cooper University HospitalCamdenUSA
  5. 5.University of ChicagoChicagoUSA
  6. 6.Stony Brook UniversityStony BrookUSA
  7. 7.Duke Clinical Research InstituteDurhamUSA

Personalised recommendations